Purchases and Sales Made in Q4 2022 in Aclaris Therapeutics, Inc. (ACRS)
This table provides information about the institutional ownership of Aclaris Therapeutics, Inc. (ACRS) during Q4 2022. The information is specifically focused on institutions that hold shares of Aclaris Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 09, 2023
Q4 2022
|
Aisling Capital Management LP
New York, NY |
SELL
|
- |
-200K- 31.52% |
$2.87M - $3.67M
|
434K
$1.26M
|
|
|
Feb 14, 2023
Q4 2022
|
Holocene Advisors, LP
New York, NY |
SELL
|
- |
-397K- 19.28% |
$5.69M - $7.3M
|
1.66M
$4.82M
|
|
|
Feb 14, 2023
Q4 2022
|
Commodore Capital LP
New York, NY |
SELL
|
- |
-530K- 22.0% |
$7.6M - $9.74M
|
1.88M
$5.45M
|
|
|
Feb 14, 2023
Q4 2022
|
Bvf Inc
San Francisco, CA |
SELL
|
- |
-700K- 17.6% |
$10M - $12.9M
|
3.28M
$9.5M
|